We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnostic Proteins Found in Patients with Sjögren's Syndrome

By HospiMedica staff writers
Posted on 16 May 2007
Sjögren's syndrome is accompanied by changes in the saliva composition, including changes in the acinar proteins.

In Sjögren's syndrome, an autoimmune disease, white blood cells attack the membranes and moisture-secreting glands of the mouth and eyes, leading to decreased production of saliva and tears. More...
The eyes can itch, burn, or feel gritty and the mouth becomes dry, hindering speech, chewing, and swallowing and may lead to dental problems. Damage to the liver, kidneys, and lungs may also occur.

Dr. Laura Giusti and colleagues from the University of Pisa (Pisa, Italy) collected whole unstimulated saliva from a panel of 12 women diagnosed with primary Sjögren's syndrome and from 12 healthy women. Proteins were removed from the centrifuged liquids by mild acid precipitation and separated from each other using two-dimensional electrophoresis, with isoelectric focusing over a wide pH range (3-10) in the first dimension, followed by gel electrophoresis. After silver staining, the protein patterns from the patients were compared with those from the healthy control subjects by image analysis.

The proteins most affected by the disease were prolactin-inducible protein precursor (PIP), carbonic anhydrase VI, alpha-amylase, albumin, and cystatins. One major change was the total disappearance of carbonic anhydrase VI in the disease saliva. This enzyme converts salivary bicarbonate into carbon dioxide and water, a process that is essential for controlling the pH of saliva, and its loss appears to correlate with the reduction in pH value for Sjögren's syndrome patients.

The levels of several cystatins in patient saliva were also reduced, in some cases to zero. These proteins protect against proteinases by regulating proteolysis and tissue damage, and their altered expression might reflect the changing balance between proteinase and protease inhibitors, so affecting the function of the saliva. The observed reduction in PIP could be linked to long-term inflammation of the oral area.

Other proteins that appeared in the disease saliva that were absent in the control samples included cyclophilin and calgranulin B. The former has been associated with immune-mediated endothelial activation and dysfunction, whereas the latter is a calcium-binding protein that is present in cases of acute and chronic inflammation.

The scientists concluded that their work has proven the validity of proteomics in the study of Sjögren's syndrome, laying the foundations for its extension into the study of connective tissue disorders in general.


Related Links:
University of Pisa

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.